Cibus is an innovative company using advanced gene editing to develop novel non-transgenic characteristics across a broad range of organisms. The company has a worldwide presence, with subsidiaries in Europe and North America and a state-of-the-art research and development center in San Diego, California. In crops, Cibus is offering its first commercial product, SU Canola, and building a pipeline of products featuring beneficial characteristics, including healthier oil profiles, disease resistance and drought tolerance. It is also using its using its RTDS technology platform to develop high value, sustainable products in microbial platforms for the food, flavor and fragrance and personal care markets. Cibus' core purpose is to lead the transition to sustainable non-transgenic products and improved human health by harvesting nature's diversity.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/28/18 | $70,000,000 | Series C |
Alexandria Venture Investments Cormorant Asset Management Fidelity Management & Research Company  | undisclosed |
